nodes	percent_of_prediction	percent_of_DWPC	metapath
Arformoterol—CYP2A6—hepatitis B	0.837	1	CbGaD
Arformoterol—Glycosuria—Entecavir—hepatitis B	0.00388	0.0242	CcSEcCtD
Arformoterol—Glycosuria—Adefovir Dipivoxil—hepatitis B	0.00379	0.0236	CcSEcCtD
Arformoterol—Hyperkalaemia—Adefovir Dipivoxil—hepatitis B	0.00301	0.0188	CcSEcCtD
Arformoterol—Musculoskeletal stiffness—Telbivudine—hepatitis B	0.00288	0.0179	CcSEcCtD
Arformoterol—Respiratory tract infection—Lamivudine—hepatitis B	0.00232	0.0144	CcSEcCtD
Arformoterol—Formoterol—CYP2A6—hepatitis B	0.0019	1	CrCbGaD
Arformoterol—Upper respiratory tract infection—Entecavir—hepatitis B	0.00183	0.0114	CcSEcCtD
Arformoterol—Hyperglycaemia—Entecavir—hepatitis B	0.00178	0.0111	CcSEcCtD
Arformoterol—Dysphonia—Lamivudine—hepatitis B	0.00177	0.011	CcSEcCtD
Arformoterol—Cramp muscle—Telbivudine—hepatitis B	0.00169	0.0105	CcSEcCtD
Arformoterol—Haematuria—Entecavir—hepatitis B	0.00168	0.0104	CcSEcCtD
Arformoterol—Nasopharyngitis—Telbivudine—hepatitis B	0.00168	0.0104	CcSEcCtD
Arformoterol—Gastritis—Telbivudine—hepatitis B	0.00166	0.0103	CcSEcCtD
Arformoterol—Haematuria—Adefovir Dipivoxil—hepatitis B	0.00164	0.0102	CcSEcCtD
Arformoterol—Influenza—Telbivudine—hepatitis B	0.00162	0.0101	CcSEcCtD
Arformoterol—Bone disorder—Lamivudine—hepatitis B	0.00161	0.01	CcSEcCtD
Arformoterol—Viral infection—Lamivudine—hepatitis B	0.00161	0.01	CcSEcCtD
Arformoterol—Rectal haemorrhage—Lamivudine—hepatitis B	0.00161	0.01	CcSEcCtD
Arformoterol—Sinusitis—Adefovir Dipivoxil—hepatitis B	0.00161	0.01	CcSEcCtD
Arformoterol—Oedema peripheral—Entecavir—hepatitis B	0.00156	0.00968	CcSEcCtD
Arformoterol—Pharyngitis—Adefovir Dipivoxil—hepatitis B	0.00153	0.00952	CcSEcCtD
Arformoterol—Urinary tract disorder—Adefovir Dipivoxil—hepatitis B	0.00152	0.00947	CcSEcCtD
Arformoterol—Connective tissue disorder—Adefovir Dipivoxil—hepatitis B	0.00151	0.00942	CcSEcCtD
Arformoterol—Urethral disorder—Adefovir Dipivoxil—hepatitis B	0.00151	0.0094	CcSEcCtD
Arformoterol—Upper respiratory tract infection—Telbivudine—hepatitis B	0.00151	0.00938	CcSEcCtD
Arformoterol—Inflammation—Lamivudine—hepatitis B	0.0015	0.00934	CcSEcCtD
Arformoterol—Immune system disorder—Entecavir—hepatitis B	0.00143	0.00888	CcSEcCtD
Arformoterol—Mental disorder—Entecavir—hepatitis B	0.00138	0.00861	CcSEcCtD
Arformoterol—Malnutrition—Entecavir—hepatitis B	0.00137	0.00856	CcSEcCtD
Arformoterol—Malnutrition—Adefovir Dipivoxil—hepatitis B	0.00134	0.00835	CcSEcCtD
Arformoterol—Back pain—Adefovir Dipivoxil—hepatitis B	0.0013	0.00808	CcSEcCtD
Arformoterol—Pharyngitis—Telbivudine—hepatitis B	0.00129	0.00801	CcSEcCtD
Arformoterol—Connective tissue disorder—Telbivudine—hepatitis B	0.00127	0.00793	CcSEcCtD
Arformoterol—Sleep disorder—Lamivudine—hepatitis B	0.00122	0.0076	CcSEcCtD
Arformoterol—Gastroenteritis—Lamivudine—hepatitis B	0.00119	0.00742	CcSEcCtD
Arformoterol—Cough—Adefovir Dipivoxil—hepatitis B	0.00117	0.00729	CcSEcCtD
Arformoterol—Mediastinal disorder—Telbivudine—hepatitis B	0.00117	0.00728	CcSEcCtD
Arformoterol—Unspecified disorder of skin and subcutaneous tissue—Entecavir—hepatitis B	0.00116	0.00723	CcSEcCtD
Arformoterol—Injury—Lamivudine—hepatitis B	0.00115	0.00716	CcSEcCtD
Arformoterol—Myalgia—Adefovir Dipivoxil—hepatitis B	0.00114	0.00711	CcSEcCtD
Arformoterol—Chest pain—Adefovir Dipivoxil—hepatitis B	0.00114	0.00711	CcSEcCtD
Arformoterol—Unspecified disorder of skin and subcutaneous tissue—Adefovir Dipivoxil—hepatitis B	0.00113	0.00706	CcSEcCtD
Arformoterol—Malnutrition—Telbivudine—hepatitis B	0.00113	0.00703	CcSEcCtD
Arformoterol—Anaphylactic shock—Entecavir—hepatitis B	0.00112	0.00698	CcSEcCtD
Arformoterol—Infection—Entecavir—hepatitis B	0.00111	0.00694	CcSEcCtD
Arformoterol—Dysgeusia—Telbivudine—hepatitis B	0.00111	0.00688	CcSEcCtD
Arformoterol—Nervous system disorder—Entecavir—hepatitis B	0.0011	0.00685	CcSEcCtD
Arformoterol—Back pain—Telbivudine—hepatitis B	0.00109	0.0068	CcSEcCtD
Arformoterol—Skin disorder—Entecavir—hepatitis B	0.00109	0.00678	CcSEcCtD
Arformoterol—Muscle spasms—Telbivudine—hepatitis B	0.00109	0.00676	CcSEcCtD
Arformoterol—Hypoglycaemia—Lamivudine—hepatitis B	0.00108	0.00674	CcSEcCtD
Arformoterol—Nervous system disorder—Adefovir Dipivoxil—hepatitis B	0.00107	0.00668	CcSEcCtD
Arformoterol—Skin disorder—Adefovir Dipivoxil—hepatitis B	0.00106	0.00662	CcSEcCtD
Arformoterol—Ill-defined disorder—Telbivudine—hepatitis B	0.00105	0.00652	CcSEcCtD
Arformoterol—Malaise—Telbivudine—hepatitis B	0.00102	0.00634	CcSEcCtD
Arformoterol—Insomnia—Entecavir—hepatitis B	0.00101	0.00632	CcSEcCtD
Arformoterol—Somnolence—Entecavir—hepatitis B	0.000997	0.00621	CcSEcCtD
Arformoterol—Musculoskeletal discomfort—Adefovir Dipivoxil—hepatitis B	0.000997	0.00621	CcSEcCtD
Arformoterol—Dyspepsia—Entecavir—hepatitis B	0.000987	0.00615	CcSEcCtD
Arformoterol—Cough—Telbivudine—hepatitis B	0.000985	0.00613	CcSEcCtD
Arformoterol—Dehydration—Lamivudine—hepatitis B	0.000983	0.00612	CcSEcCtD
Arformoterol—Gastrointestinal disorder—Entecavir—hepatitis B	0.000968	0.00603	CcSEcCtD
Arformoterol—Fatigue—Entecavir—hepatitis B	0.000967	0.00602	CcSEcCtD
Arformoterol—Dyspepsia—Adefovir Dipivoxil—hepatitis B	0.000963	0.006	CcSEcCtD
Arformoterol—Chest pain—Telbivudine—hepatitis B	0.000961	0.00598	CcSEcCtD
Arformoterol—Myalgia—Telbivudine—hepatitis B	0.000961	0.00598	CcSEcCtD
Arformoterol—Arthralgia—Telbivudine—hepatitis B	0.000961	0.00598	CcSEcCtD
Arformoterol—Unspecified disorder of skin and subcutaneous tissue—Telbivudine—hepatitis B	0.000955	0.00594	CcSEcCtD
Arformoterol—Cramp muscle—Lamivudine—hepatitis B	0.000951	0.00592	CcSEcCtD
Arformoterol—Discomfort—Telbivudine—hepatitis B	0.00095	0.00591	CcSEcCtD
Arformoterol—Gastrointestinal disorder—Adefovir Dipivoxil—hepatitis B	0.000945	0.00588	CcSEcCtD
Arformoterol—Nasopharyngitis—Lamivudine—hepatitis B	0.000945	0.00588	CcSEcCtD
Arformoterol—Gastrointestinal pain—Entecavir—hepatitis B	0.000917	0.00571	CcSEcCtD
Arformoterol—Influenza—Lamivudine—hepatitis B	0.000913	0.00569	CcSEcCtD
Arformoterol—Nervous system disorder—Telbivudine—hepatitis B	0.000904	0.00563	CcSEcCtD
Arformoterol—Skin disorder—Telbivudine—hepatitis B	0.000895	0.00557	CcSEcCtD
Arformoterol—Gastrointestinal pain—Adefovir Dipivoxil—hepatitis B	0.000895	0.00557	CcSEcCtD
Arformoterol—Body temperature increased—Entecavir—hepatitis B	0.000887	0.00552	CcSEcCtD
Arformoterol—Abdominal pain—Entecavir—hepatitis B	0.000887	0.00552	CcSEcCtD
Arformoterol—Bronchitis—Lamivudine—hepatitis B	0.000878	0.00547	CcSEcCtD
Arformoterol—Abdominal pain—Adefovir Dipivoxil—hepatitis B	0.000865	0.00539	CcSEcCtD
Arformoterol—Body temperature increased—Adefovir Dipivoxil—hepatitis B	0.000865	0.00539	CcSEcCtD
Arformoterol—Musculoskeletal discomfort—Telbivudine—hepatitis B	0.00084	0.00523	CcSEcCtD
Arformoterol—Insomnia—Telbivudine—hepatitis B	0.000833	0.00519	CcSEcCtD
Arformoterol—Hyperglycaemia—Lamivudine—hepatitis B	0.000824	0.00513	CcSEcCtD
Arformoterol—Dyspepsia—Telbivudine—hepatitis B	0.000811	0.00505	CcSEcCtD
Arformoterol—Asthenia—Entecavir—hepatitis B	0.000805	0.00501	CcSEcCtD
Arformoterol—Gastrointestinal disorder—Telbivudine—hepatitis B	0.000796	0.00495	CcSEcCtD
Arformoterol—Fatigue—Telbivudine—hepatitis B	0.000794	0.00495	CcSEcCtD
Arformoterol—Pain—Telbivudine—hepatitis B	0.000788	0.00491	CcSEcCtD
Arformoterol—Asthenia—Adefovir Dipivoxil—hepatitis B	0.000785	0.00489	CcSEcCtD
Arformoterol—Pruritus—Adefovir Dipivoxil—hepatitis B	0.000774	0.00482	CcSEcCtD
Arformoterol—Diarrhoea—Entecavir—hepatitis B	0.000767	0.00478	CcSEcCtD
Arformoterol—Sinusitis—Lamivudine—hepatitis B	0.000764	0.00476	CcSEcCtD
Arformoterol—Feeling abnormal—Telbivudine—hepatitis B	0.000759	0.00473	CcSEcCtD
Arformoterol—Gastrointestinal pain—Telbivudine—hepatitis B	0.000754	0.00469	CcSEcCtD
Arformoterol—Diarrhoea—Adefovir Dipivoxil—hepatitis B	0.000749	0.00466	CcSEcCtD
Arformoterol—Dizziness—Entecavir—hepatitis B	0.000742	0.00462	CcSEcCtD
Arformoterol—Rhinitis—Lamivudine—hepatitis B	0.000733	0.00456	CcSEcCtD
Arformoterol—Body temperature increased—Telbivudine—hepatitis B	0.000728	0.00453	CcSEcCtD
Arformoterol—Abdominal pain—Telbivudine—hepatitis B	0.000728	0.00453	CcSEcCtD
Arformoterol—Pharyngitis—Lamivudine—hepatitis B	0.000725	0.00452	CcSEcCtD
Arformoterol—Connective tissue disorder—Lamivudine—hepatitis B	0.000718	0.00447	CcSEcCtD
Arformoterol—Vomiting—Entecavir—hepatitis B	0.000713	0.00444	CcSEcCtD
Arformoterol—Rash—Entecavir—hepatitis B	0.000707	0.0044	CcSEcCtD
Arformoterol—Dermatitis—Entecavir—hepatitis B	0.000707	0.0044	CcSEcCtD
Arformoterol—Headache—Entecavir—hepatitis B	0.000703	0.00437	CcSEcCtD
Arformoterol—Vomiting—Adefovir Dipivoxil—hepatitis B	0.000696	0.00433	CcSEcCtD
Arformoterol—Rash—Adefovir Dipivoxil—hepatitis B	0.00069	0.0043	CcSEcCtD
Arformoterol—Dermatitis—Adefovir Dipivoxil—hepatitis B	0.000689	0.00429	CcSEcCtD
Arformoterol—Headache—Adefovir Dipivoxil—hepatitis B	0.000686	0.00427	CcSEcCtD
Arformoterol—Nausea—Entecavir—hepatitis B	0.000666	0.00415	CcSEcCtD
Arformoterol—Asthenia—Telbivudine—hepatitis B	0.000661	0.00412	CcSEcCtD
Arformoterol—Immune system disorder—Lamivudine—hepatitis B	0.00066	0.00411	CcSEcCtD
Arformoterol—Mediastinal disorder—Lamivudine—hepatitis B	0.000659	0.0041	CcSEcCtD
Arformoterol—Pruritus—Telbivudine—hepatitis B	0.000652	0.00406	CcSEcCtD
Arformoterol—Nausea—Adefovir Dipivoxil—hepatitis B	0.00065	0.00405	CcSEcCtD
Arformoterol—Malnutrition—Lamivudine—hepatitis B	0.000636	0.00396	CcSEcCtD
Arformoterol—Diarrhoea—Telbivudine—hepatitis B	0.00063	0.00393	CcSEcCtD
Arformoterol—Tension—Lamivudine—hepatitis B	0.000624	0.00389	CcSEcCtD
Arformoterol—Dysgeusia—Lamivudine—hepatitis B	0.000623	0.00388	CcSEcCtD
Arformoterol—Nervousness—Lamivudine—hepatitis B	0.000618	0.00385	CcSEcCtD
Arformoterol—Back pain—Lamivudine—hepatitis B	0.000615	0.00383	CcSEcCtD
Arformoterol—Muscle spasms—Lamivudine—hepatitis B	0.000612	0.00381	CcSEcCtD
Arformoterol—Dizziness—Telbivudine—hepatitis B	0.000609	0.00379	CcSEcCtD
Arformoterol—Tremor—Lamivudine—hepatitis B	0.000596	0.00371	CcSEcCtD
Arformoterol—Ill-defined disorder—Lamivudine—hepatitis B	0.00059	0.00368	CcSEcCtD
Arformoterol—Vomiting—Telbivudine—hepatitis B	0.000586	0.00365	CcSEcCtD
Arformoterol—Angioedema—Lamivudine—hepatitis B	0.000581	0.00362	CcSEcCtD
Arformoterol—Rash—Telbivudine—hepatitis B	0.000581	0.00362	CcSEcCtD
Arformoterol—Dermatitis—Telbivudine—hepatitis B	0.00058	0.00361	CcSEcCtD
Arformoterol—Headache—Telbivudine—hepatitis B	0.000577	0.00359	CcSEcCtD
Arformoterol—Malaise—Lamivudine—hepatitis B	0.000574	0.00357	CcSEcCtD
Arformoterol—Cough—Lamivudine—hepatitis B	0.000555	0.00346	CcSEcCtD
Arformoterol—Nausea—Telbivudine—hepatitis B	0.000547	0.00341	CcSEcCtD
Arformoterol—Arthralgia—Lamivudine—hepatitis B	0.000542	0.00337	CcSEcCtD
Arformoterol—Chest pain—Lamivudine—hepatitis B	0.000542	0.00337	CcSEcCtD
Arformoterol—Myalgia—Lamivudine—hepatitis B	0.000542	0.00337	CcSEcCtD
Arformoterol—Anxiety—Lamivudine—hepatitis B	0.00054	0.00336	CcSEcCtD
Arformoterol—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—hepatitis B	0.000538	0.00335	CcSEcCtD
Arformoterol—Discomfort—Lamivudine—hepatitis B	0.000535	0.00333	CcSEcCtD
Arformoterol—Dry mouth—Lamivudine—hepatitis B	0.00053	0.0033	CcSEcCtD
Arformoterol—Oedema—Lamivudine—hepatitis B	0.000519	0.00323	CcSEcCtD
Arformoterol—Anaphylactic shock—Lamivudine—hepatitis B	0.000519	0.00323	CcSEcCtD
Arformoterol—Infection—Lamivudine—hepatitis B	0.000516	0.00321	CcSEcCtD
Arformoterol—Nervous system disorder—Lamivudine—hepatitis B	0.000509	0.00317	CcSEcCtD
Arformoterol—Skin disorder—Lamivudine—hepatitis B	0.000504	0.00314	CcSEcCtD
Arformoterol—Hypotension—Lamivudine—hepatitis B	0.000485	0.00302	CcSEcCtD
Arformoterol—Musculoskeletal discomfort—Lamivudine—hepatitis B	0.000473	0.00295	CcSEcCtD
Arformoterol—Insomnia—Lamivudine—hepatitis B	0.00047	0.00292	CcSEcCtD
Arformoterol—Dyspnoea—Lamivudine—hepatitis B	0.000463	0.00288	CcSEcCtD
Arformoterol—Somnolence—Lamivudine—hepatitis B	0.000462	0.00287	CcSEcCtD
Arformoterol—Dyspepsia—Lamivudine—hepatitis B	0.000457	0.00285	CcSEcCtD
Arformoterol—Gastrointestinal disorder—Lamivudine—hepatitis B	0.000448	0.00279	CcSEcCtD
Arformoterol—Fatigue—Lamivudine—hepatitis B	0.000448	0.00279	CcSEcCtD
Arformoterol—Pain—Lamivudine—hepatitis B	0.000444	0.00276	CcSEcCtD
Arformoterol—Constipation—Lamivudine—hepatitis B	0.000444	0.00276	CcSEcCtD
Arformoterol—Feeling abnormal—Lamivudine—hepatitis B	0.000428	0.00266	CcSEcCtD
Arformoterol—Gastrointestinal pain—Lamivudine—hepatitis B	0.000425	0.00264	CcSEcCtD
Arformoterol—Urticaria—Lamivudine—hepatitis B	0.000413	0.00257	CcSEcCtD
Arformoterol—Body temperature increased—Lamivudine—hepatitis B	0.000411	0.00256	CcSEcCtD
Arformoterol—Abdominal pain—Lamivudine—hepatitis B	0.000411	0.00256	CcSEcCtD
Arformoterol—Hypersensitivity—Lamivudine—hepatitis B	0.000383	0.00238	CcSEcCtD
Arformoterol—Asthenia—Lamivudine—hepatitis B	0.000373	0.00232	CcSEcCtD
Arformoterol—Pruritus—Lamivudine—hepatitis B	0.000367	0.00229	CcSEcCtD
Arformoterol—Diarrhoea—Lamivudine—hepatitis B	0.000355	0.00221	CcSEcCtD
Arformoterol—Dizziness—Lamivudine—hepatitis B	0.000343	0.00214	CcSEcCtD
Arformoterol—Vomiting—Lamivudine—hepatitis B	0.00033	0.00206	CcSEcCtD
Arformoterol—Rash—Lamivudine—hepatitis B	0.000327	0.00204	CcSEcCtD
Arformoterol—Dermatitis—Lamivudine—hepatitis B	0.000327	0.00204	CcSEcCtD
Arformoterol—Headache—Lamivudine—hepatitis B	0.000325	0.00203	CcSEcCtD
Arformoterol—Nausea—Lamivudine—hepatitis B	0.000308	0.00192	CcSEcCtD
